Status:
COMPLETED
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
St. Petersburg State Pavlov Medical University
Conditions:
Heroin Dependence
Opioid-Related Disorders
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
PHASE3
Brief Summary
Heroin addiction is a growing problem in Russia; individuals who enter heroin addiction treatment often relapse. Therefore, effective heroin addiction treatments are necessary to prevent relapse. The ...
Detailed Description
The usual treatment of heroin addiction in Russia involves detoxification and 2-4 weeks of rehabilitation with referral to outpatient follow-up. Though most patients complete inpatient treatment, few ...
Eligibility Criteria
Inclusion
- Current opioid dependence
- Recently completed opioid detoxification
Exclusion
- Serious medical or psychiatric condition requiring immediate hospitalization or that would make participation in the study hazardous
- Planning to leave the study area within the 12 months following study entry
- Imminent incarceration
- Pregnancy
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2010
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT00218426
Start Date
July 1 2006
End Date
November 4 2010
Last Update
March 18 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178
2
Pavlov Medical University
Saint Petersburg, Russia, 197022